Glaukos (GKOS) EBT (2014 - 2026)

Glaukos (GKOS) has 13 years of EBT data on file, last reported at -$19.3 million in Q1 2026.

• EBT for Q1 2026 came in at -$19.3 million, down 8.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (down 87.47% YoY), and the FY2025 annual result was $4.6 million, up 106.29% from the prior year.
• EBT slipped to -$19.3 million in Q1 2026 per GKOS's latest filing, from $57.8 million in the prior quarter.
• Over five years, EBT peaked at $114.1 million in Q4 2024 and troughed at -$50.2 million in Q2 2024.
• A 5-year average of -$300764.7 and a median of -$19.4 million in 2025 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2023: EBT soared 388.25% in 2022, then sank 700.12% in 2023.
• A 5-year view of EBT shows it stood at $70.2 million in 2022, then surged by 44.66% to $101.5 million in 2023, then climbed by 12.46% to $114.1 million in 2024, then tumbled by 49.34% to $57.8 million in 2025, then plunged by 133.38% to -$19.3 million in 2026.
• Business Quant data shows GKOS's EBT at -$19.3 million in Q1 2026, $57.8 million in Q4 2025, and -$16.0 million in Q3 2025.